Literature DB >> 25004207

First CRISPR-Cas patent opens race to stake out intellectual property.

Cormac Sheridan.   

Abstract

Mesh：

Year:  2014        PMID： 25004207     DOI： 10.1038/nbt0714-599

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Biotechnology: Rewriting a genome.

Authors:  Emmanuelle Charpentier; Jennifer A Doudna
Journal:  Nature       Date:  2013-03-07       Impact factor: 49.962

2.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

3.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728
  3 in total
  10 in total

1.  DuPont in CRISPR-Cas patent land grab.

Authors:  Daniel Grushkin
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

2.  CRISPR patents to go on trial.

Authors: 
Journal:  Nat Biotechnol       Date:  2016-02       Impact factor: 54.908

3.  Who owns CRISPR-Cas9 in Europe?

Authors:  András Kupecz
Journal:  Nat Biotechnol       Date:  2014-12       Impact factor: 54.908

Review 4.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

5.  The emerging patent landscape of CRISPR-Cas gene editing technology.

Authors:  Knut J Egelie; Gregory D Graff; Sabina P Strand; Berit Johansen
Journal:  Nat Biotechnol       Date:  2016-10-11       Impact factor: 54.908

6.  The ethics of access to patented biotech research tools from universities and other research institutions.

Authors:  Knut J Egelie; Sabina P Strand; Berit Johansen; Bjørn K Myskja
Journal:  Nat Biotechnol       Date:  2018-06-06       Impact factor: 54.908

7.  CRISPR-edited crops free to enter market, skip regulation.

Authors:  Emily Waltz
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

Review 8.  Advances in genetic engineering of the avian genome: "Realising the promise".

Authors:  Timothy J Doran; Caitlin A Cooper; Kristie A Jenkins; Mark L V Tizard
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 9.  Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.

Authors:  Rodolphe Barrangou; Amanda Birmingham; Stefan Wiemann; Roderick L Beijersbergen; Veit Hornung; Anja van Brabant Smith
Journal:  Nucleic Acids Res       Date:  2015-03-23       Impact factor: 16.971

Review 10.  A CRISPR View of Biological Mechanisms.

Authors:  Eduardo Martinez; Lilia Sanchez; Neftali Vazquez; Rebecca Marks; Raechel Cedillo; Christa Respondek; Martin Holguin; Michael W Persans; Megan Keniry
Journal:  Discoveries (Craiova)       Date:  2016-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.